Cidara Touts Positive Phase II Antifungal Data By Sam | March 18, 2018 Cidara Therapeutics reported its mid-stage antifungal candidate hit its primary endpoints and is on track to begin Phase III testing later this year. Source: BioSpace Posted in BioPharma